Roche Extends Offer Period for Spark Therapeutics
May 14 2019 - 2:18AM
Dow Jones News
By Pietro Lombardi
Roche Holding AG (RO.EB) is extending the offering period for
its planned acquisition of Philadelphia biotechnology company Spark
Therapeutics Inc. (ONCE), it said Tuesday.
The offering period has been extended to June 14, it said, after
the companies decided to refile around May 23 their respective
premerger notification and report forms under the Hart-Scott-Rodino
Act.
The decision will provide the government with additional time to
complete its current review, the Swiss pharmaceutical company
said.
"The regulatory review of the transaction is ongoing, and the
parties are actively working with the government to facilitate that
process," it added.
Write to Pietro Lombardi at pietro.lombardi@dowjones.com
(END) Dow Jones Newswires
May 14, 2019 02:03 ET (06:03 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024
